Inovio Pharmaceuticals
INO
INO
104 hedge funds and large institutions have $24.5M invested in Inovio Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 35 increasing their positions, 13 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
4.02% more ownership
Funds ownership: 33% → 37.02% (+4%)
51% less capital invested
Capital invested by funds: $49.5M → $24.5M (-$25.1M)
Holders
104
Holding in Top 10
–
Calls
$373K
Puts
$79K
Top Buyers
| 1 | +$2.41M | |
| 2 | +$1.92M | |
| 3 | +$1.2M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$1.07M |
| 5 |
HCM
Highbridge Capital Management
New York
|
+$549K |
Top Sellers
| 1 | -$442K | |
| 2 | -$379K | |
| 3 | -$228K | |
| 4 |
Millennium Management
New York
|
-$175K |
| 5 |
Renaissance Technologies
New York
|
-$162K |